Back to Journals » Open Access Journal of Sports Medicine » Volume 7

Novel drugs in the management of acute mountain sickness and high altitude pulmonary edema

Authors Gaurav Sikri G, Bhattacharya A

Received 1 November 2015

Accepted for publication 6 November 2015

Published 30 December 2015 Volume 2016:7 Pages 1—3


Checked for plagiarism Yes

Editor who approved publication: Prof. Dr. Andreas Imhoff

Gaurav Sikri, Anirban Bhattacharya

Department of Physiology, Armed Forces Medical College, Wanowarie, Pune, India

We read with great interest the review article titled “Wilderness medicine at high altitude: recent developments in the field” by Shah et al.1 The authors have comprehensively summarized the recent advances in the field of high altitude medicine relevant to sports and travel medicine. However, Shah et al have described potential drugs for management of high-altitude illnesses, such as acute mountain sickness (AMS), high altitude cerebral edema, and high altitude pulmonary edema (HAPE) as one group under the section “Novel drug treatment for AMS”. The pathophysiologies of these two sets of diseases (AMS/high altitude cerebral edema as one and HAPE as another set) are different2 and hence it would have been nice to have had the novel drugs described separately to elucidate the therapeutic approach for the two different classes of diseases.

View original paper by Shah et al.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]